Fusion Pharmaceuticals Inc
FUSN
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.83B
Close$
$-0.88
104.1% downside
Current Fair Value
104.1% downsideOvervalued by 104.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.83 Billion |
|---|---|
| Enterprise Value | $1.86 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.45 |
| Beta | -0.69 |
| Outstanding Shares | 83,775,652 |
Return
| Return on Equity | -43.12% |
|---|---|
| Return on Assets | -32.20% |
| Return on Invested Capital | -35.65% |
Valuation & Multiples
| P/E Ratio | -14.9 |
|---|---|
| PEG | -38.59 |
| Price to Sales | - |
| Price to Book Ratio | 10.78 |
| Enterprise Value to Revenue | 52.11 |
| Enterprise Value to EBIT | -17.21 |
| Enterprise Value to Net Income | -18 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.22 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data